Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The Trung Tran

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Proteomics|May 3, 2017
Quantitative phosphoproteome analysis of cisplatin-induced apoptosis in Jurkat T cellsThe Trung Tran, Margarita Strozynski, Bernd Thiede
The Analyst|August 17, 2018
Absolute two-point quantification of proteins using dimethylated proteotypic peptidesThe Trung Tran, Ravi Chand Bollineni, Christian Jeffrey Koehler, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 21, 2021
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinationsMarton König, Åslaug Rudjord Lorentzen, Hilde Marie Torgauten, et al.
BMJ Neurology Open|March 16, 2026
Low risk of severe COVID-19 in vaccinated people with multiple sclerosis: a nationwide Norwegian studyTilde Harridsleff Rasmussen, Stine Schikora-Rustad, Åslaug Rudjord Lorentzen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Proteomics|May 3, 2017
Quantitative phosphoproteome analysis of cisplatin-induced apoptosis in Jurkat T cellsThe Trung Tran, Margarita Strozynski, Bernd Thiede
The Analyst|August 17, 2018
Absolute two-point quantification of proteins using dimethylated proteotypic peptidesThe Trung Tran, Ravi Chand Bollineni, Christian Jeffrey Koehler, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 21, 2021
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinationsMarton König, Åslaug Rudjord Lorentzen, Hilde Marie Torgauten, et al.
BMJ Neurology Open|March 16, 2026
Low risk of severe COVID-19 in vaccinated people with multiple sclerosis: a nationwide Norwegian studyTilde Harridsleff Rasmussen, Stine Schikora-Rustad, Åslaug Rudjord Lorentzen, et al.
Pageof 1